The Influence of the Organ Allocation Policy on a Patient's Chances of Undergoing Heart Transplantation and the Posttransplantation Survival Rate

Tsao, C.-I.; Chou, Nai‐Kuan; Chi, Nai‐Hsin; Chen, S.-C.; Ko, Wen‐Je; Yu, Hsi‐Yu; Chen, Y.-S.; Wang, Shoei‐Shen

doi:10.1016/j.transproceed.2012.03.025

Cited by 3 publications

(3 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As such, they have changed the donation process from an opt-in regulation to an opt-out regulation (presumed consent). The purpose was to increase donation rates, protect the rights of the donors, provide efficient allocation of the organs, and improve the quality and safety of transplants [5][6][7][8][9].…”

Section: Introductionmentioning

confidence: 99%

“…Nonetheless, in countries such as Canada where the donation process uses an opt-in system [10], the main strategies to increase organ and tissue donation are based either on the development of organ procurement organization (OPO) coordinators in clinical settings [11] or on the implementation of new regulations and health policies [5][6][7].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluating the Effectiveness of an Organ and Tissue Donation Regulation on Ocular Donor Notification Rates in Clinical Settings

Douville¹,

Godin²

2013

J Transplant Technol Res

View full text Add to dashboard Cite

Background: Despite the implementation of new regulations to increase organ and tissue donation, few regulations have been evaluated for their effectiveness in achieving this goal. Recently, the province of Quebec (Canada) modified Bill 125 to make notification of all potential donors to donation stakeholders mandatory in clinical settings. The purpose of this study was to evaluate the effectiveness of this new regulation on the potential ocular tissue donor notification rate in clinical settings.Methods: This study used a pre-post design to determine the impact of the new regulation on the ocular tissue donor notification rate. The notification rate of potential ocular tissue donors was measured objectively among 26 departments of five clinical settings over a period of four months, beginning three months after the adoption of the new regulation (post-test measure); the pre-test value consisted in the notification rate during the same four-month period in the previous year. Data were analyzed using generalized estimating equations.Results: The notification rate of ocular tissue donors prior to the change in the regulation (21.0%) did not increase significantly after legislative changes (21.6%) (χ2=0.01, p=0.93). Conclusion:Despite making the notification of potential organ and tissue donors mandatory, the new regulation did not change the notification rate of ocular tissue donors. Policy formulation and policy implementation are two possible reasons for this failure. In particular, it is suggested that working closely with all relevant stakeholders at the time of policy formulation should facilitate implementation strategies.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Evaluating the Effectiveness of an Organ and Tissue Donation Regulation on Ocular Donor Notification Rates in Clinical Settings

Douville¹,

Godin²

2013

J Transplant Technol Res

View full text Add to dashboard Cite

show abstract

“…Current data suggest that regional disparities exist in waiting times for heart transplantation in America, 12,13 Europe, 14,15 and Asia. 16,17 Such disparities, among others, could lead to differences in device utilization and indications for implantation among the regions. As geographic variation in indications, regulatory environments, and/or management protocols could lead to different outcomes, identification of these regional differences offers an opportunity to optimize global use of LVADs, generate new knowledge that may be shared across regions, and establish best practices.…”

mentioning

confidence: 99%

Comparative analysis of regional outcomes and adverse events after continuous-flow left ventricular assist device implantation: An IMACS analysis

Mirza

Xie

Cowger

et al. 2020

The Journal of Heart and Lung Transplantation

View full text Add to dashboard Cite

INTRODUCTION:Regional outcomes after implantation of continuous-flow left ventricular assist devices (LVADs) have not been described. We examined differences in patient selection, survival, and adverse events across 3 geographic regions of the world: the Americas, Asia-Pacific, and Europe. METHODS: Using data from The International Society for Heart and Lung Transplantation Mechanically Assisted Circulatory Support registry, all adult patients implanted with a continuous-flow LVADs were included in this International Society for Heart and Lung Transplantation Mechanically Assisted Circulatory Support analysis (n = 15,560), of whom, 9,988 (64%) received axial-flow devices and 5,572 (36%) received centrifugal-flow devices. RESULTS: There were significant interregional differences in the rate of implantation of patients aged >70 years

show abstract

The Impact of Pretransplantation Urgency Status and the Presence of a Ventricular Assist Device on Outcome After Heart Transplantation

Reser¹,

Fröhlich²,

Seifert³

et al. 2014

Transplantation Proceedings

View full text Add to dashboard Cite

The Influence of the Organ Allocation Policy on a Patient's Chances of Undergoing Heart Transplantation and the Posttransplantation Survival Rate

Cited by 3 publications

References 4 publications

Evaluating the Effectiveness of an Organ and Tissue Donation Regulation on Ocular Donor Notification Rates in Clinical Settings

Evaluating the Effectiveness of an Organ and Tissue Donation Regulation on Ocular Donor Notification Rates in Clinical Settings

Comparative analysis of regional outcomes and adverse events after continuous-flow left ventricular assist device implantation: An IMACS analysis

The Impact of Pretransplantation Urgency Status and the Presence of a Ventricular Assist Device on Outcome After Heart Transplantation

Contact Info

Product

Resources

About